new BindingDB logo
myBDB logout

18 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27287367 36 Evaluation of bisbenzamidines as inhibitors for matriptase-2.EBI University of Bonn
26421993 44 Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors.EBI Aurigene Discovery Technologies Limited
24794746 168 Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.EBI Aurigene Discovery Technologies Limited
20503967 138 Factor Xa inhibitors: next-generation antithrombotic agents.EBI Bristol-Myers Squibb Company
10956211 14 GRID/CPCA: a new computational tool to design selective ligands.EBI Boehringer Ingelheim Pharma KG
9301673 234 Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine.EBI Klinikum der Friedrich-Schiller-Universit£t Jena
10498204 25 Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA.EBI Rh£ne-Poulenc Rorer
19805567 3 Long-lasting enfuvirtide carrier pentasaccharide conjugates with potent anti-human immunodeficiency virus type 1 activity.EBI Endotis Pharma
 32 Bisbenzamidine isoxazoline derivatives as factor Xa inhibitorsEBI TBA
 13 Characterization of LY806303 as a potent and selective inhibitor of thrombinEBI TBA
16970403 74 Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position.EBI University of Antwerp
12036353 38 Design of selective thrombin inhibitors based on the (R)-Phe-Pro-Arg sequence.EBI Pfizer Global Research and Development
10636232 58 Design, synthesis and structure-activity relationship of a series of arginine aldehyde factor Xa inhibitors. Part 1: structures based on the (D)-Arg-Gly-Arg tripeptide sequence.EBI COR Therapeutics, Inc.
10560742 85 3-Amidinophenylalanine-based inhibitors of urokinase.EBI Universität Jena
9876114 111 Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.EBI Institut für Biochemie
9784099 84 Design of benzamidine-type inhibitors of factor Xa.EBI Institut für Biochemie
7473571 90 Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.EBI Lilly Research Laboratories